VCIM
Velan Capital Investment Management Portfolio holdings
AUM
$99.9M
This Quarter Return
+13.35%
1 Year Return
+37.46%
3 Year Return
+659.14%
5 Year Return
–
10 Year Return
–
AUM
$175M
AUM Growth
+$175M
(-5.6%)
Cap. Flow
-$17.4M
Cap. Flow
% of AUM
-9.98%
Top 10 Holdings %
Top 10 Hldgs %
95.55%
Holding
25
New
4
Increased
2
Reduced
3
Closed
6
Top Buys
| 1 |
Skye Bioscience
SKYE
|
$3.38M |
| 2 |
Context Therapeutics
CNTX
|
$2.59M |
| 3 |
Rezolute
RZLT
|
$1.72M |
| 4 |
Protara Therapeutics
TARA
|
$998K |
| 5 |
X4 Pharmaceuticals
XFOR
|
$382K |
Top Sells
| 1 |
ADMA Biologics
ADMA
|
$10.1M |
| 2 |
Kiora Pharmaceuticals
KPRX
|
$4.11M |
| 3 |
Inspire Medical Systems
INSP
|
$3.87M |
| 4 |
Aquestive Therapeutics
AQST
|
$2.56M |
| 5 |
Outlook Therapeutics
OTLK
|
$1.87M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALIM
1
DELISTED
Alimera Sciences, Inc.
ALIM
| $75.7M | 43.35% | 13,608,533 | – | – |
|
2
Jasper Therapeutics
JSPR
$45.5M
| $32.5M | 18.65% | 1,471,904 | – | – |
|
3
Heron Therapeutics
HRTX
$207M
| $24.5M | 14.01% | 6,986,744 | – | – |
|
4
Praxis Precision Medicines
PRAX
$958M
| $14.5M | 8.31% | 350,666 | – | – |
|
5
Tourmaline Bio
TRML
$601M
| $4.1M | 2.35% | 319,080 | – | – |
|
6
TELA Bio
TELA
$70.5M
| $3.51M | 2.01% | 746,087 | – | – |
|
|
7
Rezolute
RZLT
$619M
| $3.44M | 1.97% | 800,000 +400,000 | +100% | +$1.72M |
|
|
8
Skye Bioscience
SKYE
$108M
| $3.38M | 1.94% | +422,142 | New | +$3.38M |
|
|
OPTN
9
DELISTED
OptiNose
OPTN
| $2.59M | 1.49% | 2,492,830 -508,361 | -17% | -$529K |
|
|
10
Context Therapeutics
CNTX
$75.4M
| $2.59M | 1.48% | +1,290,323 | New | +$2.59M |
|
11
InspireMD
NSPR
$102M
| $2.26M | 1.29% | 904,029 | – | – |
|
|
12
Outlook Therapeutics
OTLK
$37.8M
| $1.82M | 1.04% | 247,084 -252,916 | -51% | -$1.87M |
|
|
ELEV
13
DELISTED
Elevation Oncology
ELEV
| $1.61M | 0.92% | 597,299 +100,000 | +20% | +$270K |
|
|
14
Protara Therapeutics
TARA
$120M
| $998K | 0.57% | +480,000 | New | +$998K |
|
|
15
Kiora Pharmaceuticals
KPRX
$9.55M
| $513K | 0.29% | 122,223 -977,777 | -89% | -$4.11M |
|
|
16
X4 Pharmaceuticals
XFOR
$84.2M
| $382K | 0.22% | +659,020 | New | +$382K |
|
|
ASLN
17
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
| $188K | 0.11% | 625,000 | – | – |
|
|
18
ADMA Biologics
ADMA
$4.12B
| – | – | -1,528,601 | Closed | -$10.1M |
|
|
19
Aquestive Therapeutics
AQST
$456M
| – | – | -600,000 | Closed | -$2.56M |
|
20
Geron
GERN
$893M
| – | – | -500,000 | Closed | -$1.65M |
|
|
21
Inspire Medical Systems
INSP
$2.77B
| – | – | -18,000 | Closed | -$3.87M |
|
22
iShares Russell 2000 ETF
IWM
$67B
| – | – | 0 | – | – |
|
23
Milestone Pharmaceuticals
MIST
$156M
| – | – | -650,000 | Closed | -$1.16M |
|
24
enVVeno Medical
NVNO
$15.4M
| – | – | -172,235 | Closed | -$937K |
|
25
SPDR S&P Biotech ETF
XBI
$5.07B
| – | – | 0 | – | – |
|